Skip to main content
. 2005 May 24;388(Pt 2):623–630. doi: 10.1042/BJ20041572

Figure 3. Activity of mCAR mutants at position 350.

Figure 3

A given expression plasmid containing each mCAR mutant (0.2 μg) was co-transfected into HepG2 cells with (NR1)5-tk-luciferase plasmid (0.1 μg) and pRL-SV40 (0.01 μg) for 16 h. Then cells were treated with DMSO or TCPOBOP (250 nM) for an additional 24 h and subjected to luciferase assay. The results are expressed as the means±S.D. from three independent experiments.